Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial

Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the history and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:57:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The new page footer shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:18:49.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page history shows a new revision entry (v3.3.2) and removal of the previous revision (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T19:00:19.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The government funding/operating status notice shown on the page has been removed. This change does not affect the study data, version history, or how users access information on the page.
    Difference
    0.4%
    Check dated 2025-11-17T18:07:03.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Old and New screenshots show the same record history for NCT03521934; only the visual layout appears different, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T12:44:07.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    9%
    Check dated 2025-10-05T17:25:40.000Z thumbnail image

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.